StockData
Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc. (NAUT) stock

NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 6/30
$2.43+0.07 (+2.97%)

Close on Nov 18, 2026Market cap $309.52MP/E –Yield –

Nautilus Biotechnology operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2021Mar 31, 2021-$1.78M–
Q3 FY2020Sep 30, 2020-$174.67K–

More Nautilus Biotechnology figures

See a number that looks wrong?